Agilent Technologies and Transcriptic Collaborate to Automate Discovery Biology
December 08 2016 - 11:00AM
Business Wire
Agilent Technologies Inc. (NYSE:A) and Transcriptic Inc. have
agreed to partner their technologies to provide a solution for
convenient, broad scale synthetic and discovery biology
research.
Agilent continues its strong program of fostering innovation
using the Agilent portfolio by collaborating with rising companies
such as Transcriptic to develop novel synthetic biology solutions.
Transcriptic’s automated discovery biology platform enables
scalable life science research through a convenient and simple web
interface. Biologists who use the platform can control their
science and generate data remotely via the cloud.
Transcriptic will add multiple Agilent Genomics product lines
for mutagenesis and cloning to the protocol library within the
Transcriptic robotic cloud laboratory. The first in the series –
QuikChange Lightning – will accelerate the generation of multiple
mutants for large protein function projects. Providing cutting-edge
Agilent bioreagents in a robotic laboratory setting will allow a
global customer base to automate and optimize workflows for rapid
and efficient research discoveries.
“We’re excited to combine our genome engineering tools with
automated experimentation,” said Herman Verrelst, Agilent vice
president and general manager of the company’s Genomics Solutions
Division and Clinical Applications Division. “Transcriptic’s
services are validated, scalable, and accessible from anywhere in
the world, which will enhance the market for our industry-leading
reagents.”
“Agilent QuikChange site-directed mutagenesis kits have an
unsurpassed reputation for being reliable and easy to use,” said
Yvonne Linney, chief operating officer at Transcriptic. “By
bringing these products to Transcriptic, we will make it extremely
easy for customers to scale up their research, using many mutants
to produce very large datasets for exploring protein function.”
The companies recently presented the combined solution at the
iGEM 2016 Giant Jamboree to teams of budding synthetic biologists
from around the world.
For more information, visit
https://learn.transcriptic.com/quikchange-lightning
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in
life sciences, diagnostics and applied chemical markets, is the
premier laboratory partner for a better world. Agilent works with
customers in more than 100 countries, providing instruments,
software, services and consumables for the entire laboratory
workflow. The company generated revenues of $4.20 billion in fiscal
2016 and employs about 12,500 people worldwide. Information about
Agilent is available at www.agilent.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161208005083/en/
Agilent TechnologiesVictoria Wadsworth-Hansen, +1
408-553-2005+45 29336980victoria.wadsworth-hansen@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Sep 2023 to Sep 2024